Cytosorbents (CTSO) FCF Margin Growth (1y) (2012 - 2026)
Cytosorbents (CTSO) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,833.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2,811.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -125.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 2,651.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,651.00 |
| Dec 31, 2025 | -3,010.00 |
| Sep 30, 2025 | 301.00 |
| Jun 30, 2025 | 3,835.00 |
| Mar 31, 2025 | 1,449.00 |
| Dec 31, 2024 | 5,681.00 |
| Sep 30, 2024 | 2,873.00 |
| Jun 30, 2024 | 1,917.00 |
| Mar 31, 2024 | -2,134.00 |
| Dec 31, 2023 | -8,198.00 |
| Sep 30, 2023 | 9,352.00 |
| Jun 30, 2023 | 1,539.00 |
| Mar 31, 2023 | 6,869.00 |
| Dec 31, 2022 | 8,655.00 |
| Sep 30, 2022 | -12,273.00 |
| Jun 30, 2022 | -6,549.00 |
| Mar 31, 2022 | -7,543.00 |
| Dec 31, 2021 | -7,450.00 |
| Sep 30, 2021 | 344.00 |
| Jun 30, 2021 | -4,245.00 |